再次調漲電池片價格 通威股份(600438.SH)大漲近8%創2個月新高
格隆匯5月10日丨入選了格隆匯2021年“下注中國”十大核心潛力資產的通威股份(600438.SH)今日大漲,半日收漲7.92%報38.85元,股價創今年3月4日以來新高,最新市值1749億元。通威官網5月6日發佈最新電池片定價公吿,對比4月25日報價,其中多晶金剛線157電池定價上漲0.03元至0.76元/W,單晶PERC158.75電池定價0.96元/W,持平;單晶PERC166電池定價上漲0.03元至0.92元/W,單晶PERC210電池定價上漲0.02元至0.92元/W。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.